The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Tumor regression and growth rates determined in two intramural NCI prostate cancer trials: The growth rate constant as an indicator of therapeutic efficacy.
Bamidele Adesunloye
No relevant relationships to disclose
Wilfred Donald Stein
No relevant relationships to disclose
Julia Wilkerson
No relevant relationships to disclose
Xuan Huang
No relevant relationships to disclose
Fatima H Karzai
No relevant relationships to disclose
Ravi A. Madan
No relevant relationships to disclose
Andrea Borghese Apolo
No relevant relationships to disclose
William Douglas Figg
No relevant relationships to disclose
William L. Dahut
No relevant relationships to disclose
Tito Fojo
No relevant relationships to disclose